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ABSTRACT The b-subunit of the dihydropyridine receptor (DHPR) enhances the Ca2þ channel and voltage-sensing functions
of the DHPR. In skeletal myotubes, there is additional modulation of DHPR functions imposed by the presence of ryanodine
receptor type-1 (RyR1). Here, we examined the participation of the b-subunit in the expression of L-type Ca2þ current and
charge movements in RyR1 knock-out (KO), b1 KO, and double b1/RyR1 KO myotubes generated by mating heterozygous b1
KO and RyR1 KO mice. Primary myotube cultures of each genotype were transfected with various b-isoforms and then whole-
cell voltage-clamped for measurements of Ca2þ and gating currents. Overexpression of the endogenous skeletal b1a isoform
resulted in a low-density Ca2þ current either in RyR1 KO (36 6 9 pS/pF) or in b1/RyR1 KO (346 7 pS/pF) myotubes. However,
the heterologous b2a variant with a double cysteine motif in the N-terminus (C3, C4), recovered a Ca2þ current that was entirely
wild-type in density in RyR1 KO (195 6 16 pS/pF) and was signiﬁcantly enhanced in double b1/RyR1 KO (115 6 18 pS/pF)
myotubes. Other variants tested from the four b gene families (b1a, b1b, b1c, b3, and b4) were unable to enhance Ca2þ current
expression in RyR1 KO myotubes. In contrast, intramembrane charge movements in b2a-expressing b1a/RyR1 KO myotubes
were signiﬁcantly lower than in b1a-expressing b1a/RyR1 KO myotubes, and the same tendency was observed in the RyR1 KO
myotube. Thus, b2a had a preferential ability to recover Ca2þ current, whereas b1a had a preferential ability to rescue charge
movements. Elimination of the double cysteine motif (b2a C3,4S) eliminated the RyR1-independent Ca2þ current expression.
Furthermore, Ca2þ current enhancement was observed with a b2a variant lacking the double cysteine motif and fused to the
surface membrane glycoprotein CD8. Thus, tethering the b2a variant to the myotube surface activated the DHPR Ca2þ current
and bypassed the requirement for RyR1. The data suggest that the Ca2þ current expressed by the native skeletal DHPR
complex has an inherently low density due to inhibitory interactions within the DHPR and that the b1a-subunit is critically
involved in process.
INTRODUCTION
The dihydropyridine receptor (DHPR) of skeletal muscle is
a heteropentamer composed of a1S, b1a, a2-d1, and g1
subunits. This complex forms a voltage-gated Ca2þ channel
that is specialized in coupling membrane excitation to the
opening or ryanodine receptor type 1 (RyR1) in the
sarcoplasmic reticulum (SR). Although excitation-contrac-
tion (EC) coupling requires charge movements in the DHPR,
the opening of the DHPR Ca2þ channel is not essential. Not
only is the opening of the Ca2þ channel nonessential, but it
has long been suspected that the great majority of the skeletal
DHPRs do not contribute to the Ca2þ current (Schwartz et
al., 1985). This has been suggested also by developmental
studies showing that skeletal DHPR Ca2þ current and charge
movements are differentially regulated. The maximal Ca2þ
conductance and charge movement densities of mouse
skeletal myotubes are ;140 pS/pF and 7 fC/pF during the
late gestation period (Strube et al., 1996, 2000). However, in
adult mouse fibers, the Ca2þ current density remains at
approximately the same level (85 pS/pF, Wang et al., 1999;
160 pS/pF, Jacquemond et al., 2002), but charge movements
increase manyfold (40 fC/pF, Wang et al., 1999; 25 fC/pF,
Jacquemond et al., 2002). Thus, as the myotube matures, the
DHPR complex becomes preferentially engaged in voltage-
sensing, and the excess of charge movements is likely to
represent a functional adaptation of the complex to an
increased demand for EC coupling and force generation.
A critical regulator of DHPR function is the b-subunit of
this complex. Numerous expression studies in heterologous
cells have shown that Ca2þ channel b-subunits profoundly
affect Ca2þ current expression and gating properties of volt-
age-gated Ca2þ channels (Birnbaumer et al., 1998).
b-subunits are cytoplasmic or membrane-associated proteins
of;65–75 kDa encoded by four genes. Alternate splicing of
the b1 gene produces at least three isoforms. The b1a variant
is exclusively present in skeletal muscle, whereas the other
two (b1b, b1c) are expressed in brain, heart and spleen
(Powers et al., 1992). Transcripts of the other three genes (b2,
b3, b4) were isolated from cardiac and brain cDNA libraries
(b2, Perez-Reyes et al., 1992; b3, Castellano et al., 1993a;
b4, Castellano et al., 1993b). In terms of sequence content,
b-subunits share two conserved central regions amounting to
more than half of the total peptide sequence (domains D2 and
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D4), a nonconserved linker between the two conserved
domains (D3), and nonconserved N- and C-termini (domains
D1 and D5, respectively) (Perez-Reyes and Schneider, 1994).
The main interaction of b-subunits with a1 pore subunits is
via a conserved;30-residue b-interaction domain present in
domain D4 that binds with high affinity to the cytosolic loop
between repeats I and II of the a1 subunit (Pragnell et al.,
1994; De Waard et al., 1994). However, secondary inter-
actions with other loops of pore subunits have been
documented, especially for the neuronal a1A isoform
(Walker et al., 1998). In terms of domain homology,
b-subunits are related to the membrane-associated guanylate
kinase superfamily, commonly engaged in membrane
signaling. All members of this family have PDZ, SH3, and
guanylate kinase homology domains which, in b-subunits,
are present in the conserved D2 and D4 regions (Hanlon
et al., 1999).
Structure-function studies have suggested roles for
b-subunits in three distinct areas of DHPR function. First,
b-subunits increase surface expression of Ca2þ channels;
hence, this protein is vital for trafficking the newly
synthesized DHPR out of perinuclear sites (Chien et al.,
1995; Neuhuber et al., 1998; Bichet et al., 2000). Second,
b-subunits modulate the kinetics of the L-type Ca2þ current
(Qin et al., 1998; Wei et al., 2000; Berrou et al., 2001) and
increase the coupling between S4 charge movements and
pore opening (Neely et al., 1993; Kamp et al., 1996; Olcese
et al., 1996). Finally, the b1a subunit is required for the
voltage dependent triggering of Ca2þ transients in skeletal
muscle, suggesting that
b-participates in coupling charge movements to the opening
of RyR1 (Beurg et al., 1999a,b; Sheridan et al., 2002).
Studies in HEK cells, aiming to identify the molecular basis
of the transport function of b2a, showed that neither D1 nor
D5 was essential for the surface expression of Ca2þ channels
formed by a1C or for the expression of DHP binding sites
accessible from the outside of the cell (Gao et al., 1999).
However, mutations in the b-interaction domain region and
the nearby SH3 region abolished surface expression (Chien
et al., 1998). Hence, a strong a1/b interaction is vital for the
survival of the newly synthesized Ca2þ channel. In terms of
the functional identity of other domains present in the
b-subunit, the N-terminus in domain D1 is a critical
determinant of the rate and voltage dependence of activation
of Ca2þ channels formed by the a1E isoform (Olcese et al.,
1994). A second region in domain D3 selectively affected
inactivation independent of b-effects on activation (Qin et
al., 1996). Furthermore, the C-terminus region of b1a
(domain D5) is a critical determinant of the EC coupling
function of the DHPR in skeletal myotubes (Beurg et al.,
1999a,b; Sheridan et al., 2002).
A second critical regulator of DHPR function is RyR1
itself. Studies in RyR1 KO myotubes have shown that
approximately half of the DHPR charge movements and
DHP binding sites are lost when RyR1 is eliminated.
However, the Ca2þ current density is depressed much more
severely, close to10-fold (Nakai et al., 1996; Buck et al.,
1997; Avila and Dirksen, 2000). Expression of the DHPR
Ca2þ current has been suggested to be under the specific
control of RyR1 by a so-called retrograde signal, from RyR1
to the DHPR (Nakai et al., 1998). The nature of this
retrograde signal is probably structural in origin because full
Ca2þ current recovery was observed in RyR KO myotubes
expressing RyR1 mutants strongly deficient in voltage-
dependent EC coupling (Avila et al., 2001). However, full
charge movement recovery in the RyR1 KOmyotube did not
occur with the EC coupling deficient RyR1 mutant, requiring
instead an entirely functional RyR1 (Avila et al., 2001).
Thus, the contribution of RyR1 to DHPR expression is
complex and presumably involves modulatory effects via
protein-protein interactions as well as Ca2þ signaling
mediated by RyR1. In contrast to the strict requirements
for RyR1 in the skeletal myotube, studies in amphibian
oocytes have shown that skeletal Ca2þ current expression
can be achieved by a specific combination of skeletal (a1S,
a2d, g1) and neuronal (b1b) subunits (Ren and Hall, 1997;
Morrill and Cannon, 2000). The reasons why the DHPR
Ca2þ current would require a retrograde signal from RyR1 in
the skeletal myotube but this signal would be bypassed in the
heterologous oocyte system are entirely unclear at this point.
This discrepancy suggests that in the skeletal myotube, Ca2þ
current regulation is multifactorial, and perhaps it represents
a balance of positive and negative interactions within the
DHPR and between the DHPR and other muscle proteins.
In this study, we investigated the charge movement and
Ca2þ current characteristics donated to this complex by b1a,
the endogenous variant known to form part of the skeletal
DHPR (Ruth et al., 1989), and by b2a (Perez-Reyes et al.,
1992; Qin et al., 1998), which is a variant expressed in the
heart and brain but not in skeletal muscle (Perez-Reyes and
Schneider, 1994). Studies were conducted in RyR1 KO, b1
KO, and double KO myotubes generated by interbreeding
mice heterozygous for the b1 KO and RyR1 KO alleles. The
data indicate that in the absence of RyR1, b2a had
a preferential ability to recover a DHPR that expressed
Ca2þ currents at a high density and charge movements at
a low density. Conversely, b1a had a preferential ability to
recover a DHPR that expressed charge movements at a high
density and Ca2þ currents at a low density. Thus, the
b-subunit of the skeletal DHPR appears to be intimately
involved in the cellular mechanisms that differentially
regulate charge movements and Ca2þ current expression in
the skeletal myotube. Part of this work has been previously
published in abstract form (Ahern et al., 2002).
MATERIALS AND METHODS
Identiﬁcation of genotypes
We used PCR to screen for the wild-type (WT) and knock-out (KO) alleles
of the DHPR b1 and RyR1 genes in mice with targeted disruptions of these
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genes (Gregg et al., 1996; Nakai et al., 1996). Tail samples from E18 fetuses
were digested with Proteinase K (Sigma, St. Louis, MO), and the DNA was
then isolated following the Puregene animal tissue protocol (Gentra
Systems, Minneapolis, MN). The PCR reactions for each sample were
composed of 11.7 mL distilled water, 1 mL of each 20 mM primer, 3.2 mL of
1.25 mM dNTPs (Stratagene, Cedar Creek, TX), 2 mL 103 PCR buffer
(Qiagen, Valencia, CA), 12 mL Taq polymerase (Qiagen, Valencia, CA),
and 1 mL of the DNA solution (;100 mg/mL). PCR primers 59 gga ctg gca
aga gga ccg gag 39 and 59 gga agc cag ggc tgc agg tga gc 39 were used to
amplify a 400 bp fragment of the WT RyR1 allele. PCR primers 59 gga ctg
gca aga gga ccg gag 39 and 59 cct gaa gaa cga gat cag cag cct ctg ttc c 39were
used to amplify a 300 bp fragment of the KO RyR1 allele. The following
conditions applied for the PCR of the RyR1 alleles: 1) 5 min and 30 s at
948C, 2) 1 min at 948C, 3) 1 min at 558C, 4) 1 min at 728C, 5) cycle through
steps 2–4 for 30 times, and 6) 10 min at 728C. PCR primers 59 cta gga gaa
tgg atg gta gat gg 39 and 59 aca ccc cct gcc agt ggt aag agc 39 were used to
amplify a 250 bp fragment of the WT b1 allele. PCR primers 59 aca ccc cct
gcc agt ggt aag agc 39 and 59 aca ata gca ggc atg ctg ggg atg 39 were used to
amplify a 197 bp fragment of the KO b1 allele. The following conditions
apply for the PCR of the DHPR b1 alleles: 1) 2 min at 948, 2) 30 s at 948C, 3)
45 s at 558C, 4) 1 min at 728C, 5) cycle through steps 2–4 for 30 times, and 6)
10 min at 728C.
Myotube primary cell cultures
Cell cultures of myotubes were prepared from hind limbs of E18 mice
as described (Beurg et al., 1997). Myoblasts were isolated by enzymatic
digestion with 0.125% (w/v) trypsin and 0.05% (w/v) pancreatin. After
centrifugation, mononucleated cells were resuspended in plating medium
containing 78% Dulbeccos’s modified Eagle’s medium with low glucose
(DMEM), 10% horse serum, 10% fetal bovine serum (FBS), and 2%
chicken serum extract. Cells were plated on plastic culture dishes coated
with gelatin at a density of ;1 3 104 cells per dish. Cultures were grown
at 378C in 8% CO2 gas. After the fusion of myoblasts (5–7 days), the
medium was replaced with FBS-free medium, and CO2 was decreased
to 5%.
cDNA transfection
Cell transfection was performed during myoblast fusion with the polyamine
LT1 (Panvera). Cells were exposed for 2–3 h to a transfection solution
containing LT1 and cDNA in a 5:1 ml/mg ratio. All cDNAs of interest, with
the exceptions of RyR1 and CD8-b2a C3,4S, were subcloned in the
mammalian expression vector pSG5 (Stratagene, La Jolla, CA). The RyR1
cDNA was subcloned in the pCl-neo expression vector (Promega, Madison,
WI) as described (Nakai et al., 1996). The CD8-b2a C3,4S construct is
described below. The expression plasmid was cotransfected with a plasmid
encoding the T-cell surface glycoprotein CD8A used as a transfection
marker. Transfected cells were identified with micron-size polystyrene beads
coated with a monoclonal antibody against an external CD8A epitope
(Dynal, Oslo, Norway). The efficiency of cotransfection of the marker and
the cDNA of interest was ;80%.
Full-length cDNAs
All cDNAs were N-terminus tagged by in-frame fusion of the first 11 amino
acids of the phage T7 gene 10 protein in the pSG5 vector. GenBank
accession numbers for the full-length sequences utilized in the present study
were as follows: mouse b1a residues 1–524 (NM_031173), mouse b1b
residues 1–596 (AY094173), mouse b1c residues 1–480 (AY094172), rat
b2a residues 1–604 (M80545), rat b3b residues 1–485 (M88751), and rat b4
residues 1–519 (L02315). All cDNA constructs were sequenced at least
twice at a campus facility.
b1a deletion constructs
Two oligonucleotide primers were designed to encompass the region of
interest. Each primer had 20–25 bases identical to the original sequence and
an additional 10–15 bases that resulted in an amplified product with an AgeI
site at the 59 end and a stop codon and NotI restriction site at the 39 end. The
PCR products were subcloned into the pCR-Blunt vector (Invitrogen,
Carlsbad, CA), excised by digestion with AgeI and NotI, and cloned into
pSG5.
b1aD1–57
PCR primers 59 gcat gac cgg tgg aca gca aat ggg tgg ctc agc aga gtc cta cac 39
and 59 gcg gcc gct agc tac cta cat ggc gtg ctc ctg agg 39were used to generate
a cDNA that contains amino acids 58–524 of the b1a cDNA. This cDNA
was fused in frame to the first 11 amino acids of the phage T7 gene 10
protein in the pSG5 vector.
b1aD490–524
PCR primers 59 gca tga ccg gtg gac agc aaa tgg gta tgg tcc aga aga gcg gca
tgt ccc ggg gcc 39 and 59 ggg gcg gcc gct cac tgg agg ttg gag acg ggg gca 39
were used to generate a cDNA that contains amino acids 1–489 of the b1a
cDNA. This cDNA was fused in frame to the first 11 amino acids of the
phage T7 gene 10 protein in the pSG5 vector.
Cysteine substitution constructs
b1a Q3C, K4C
Forward primer 59 acc ggt gga aca gca aat ggg tat ggt ctg ctg cag ggg cat g 39
and reverse primer 59 att gta gcc aac att tgt ccg aac agc 39 were used to
introduce nucleotides for cysteines at residue positions three and four in the
b1a template. Primers (10 pmol each), 20 pmol dNTPs, 20 ng T7-b1a-pSG5
template, and 0.5 ml Taq polymerase (Promega, Madison, WI) were
combined and cycled at 958C for 5 min then 958C for 2 min, 558C for 1 min,
and 728C for 1 min for 30 cycles ending with 10 min at 728C. The PCR
product was ligated into pCR 2.1 TA vector (Stratagene, Carlsbad, CA).
This cDNA was then inserted into T7-b1a-pSG5 via unique AgeI and XhoI
sites.
b2a C3,4S
Forward primer 59 acc ggt gga cag caa atg gta tgc agt cct ccg ggc 39and
reverse primer 59 cat atc tgt gac ctc ata cc 39 were used to introduce
nucleotides for serines at residue positions three and four in the b2a temp-
late. Primers (10 pmol each), 20 pmol dNTPs, 20 ng T7-b2a-pSG5 template,
and 0.5 ml Taq polymerase (Promega, Madison, WI) were combined and
cycled at 958C for 5 min then 958C for 2 min, 558C for 1 min and 728C for
1 min for 30 cycles finishing with 10 min at 728C. The PCR product was
cloned into pCR 2.1 TA vector (Stratagene, Carlsbad, CA). This cDNA was
then inserted into T7-b2a-pSG5 via unique AgeI and Acc65I sites.
Chimeric b2aD1–3b1aD4,5
(b2a 1–287/b1a 325–524)
This construct contains amino acids 1–287 of b2a fused to the N-terminus of
amino acids 325–524 of b1a and was made by two rounds of PCR. Primers
59 gca tga ccg gtg gac agc aaa tgg gta tgc agt gct gcg ggc tgg ta 39 (A) and 59
gag cgt ttg gcc agg gag atg tca gca 39 (B) were used to PCR the 59 end of the
full-length b1a cDNA. Primers 59 tcc ctg gcc aaa cgc tcc gtc ctc aac 39 (C)
and 59 gcg gcc gct agc tac cta cat ggc gtg ctc ctg agg 39 (D) were used to PCR
the 39 end of the full-length b1a cDNA. The primers were designed to
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produce a 17 bp overlap of identical sequence. The two PCR products were
electrophoresed on agarose gels, excised from the gel, and eluted using
GenElute columns (Supelco, Bellefonte, PA). The two PCR products were
mixed in an equimolar ratio, denatured, allowed to reanneal, and used in
a PCR reaction to amplify the chimeric fragments with primers A and D.
This cDNA was fused in frame to the first 11 amino acids of the phage T7
gene 10 protein in the pSG5 vector.
Chimeric b2aD1b1aD2–5 (b2a 1–16/b1a 58–524)
This construct contains amino acids 1–16 of b2a cDNA fused to the
N-terminus of amino acids 58–524 of b1a cDNA and was made by one
round of PCR. Forward primer 59 gga tcc atg cag tgc tgc ggg ctg gta cat cgc
cgg cga gta cgg gtc cgc cag ggc tca gc 39 encodes a portion of the N-terminal
T7 tag, the first 16 residues of b2a and b1a residues 58–67. This
‘‘overhang’’ primer was combined with reverse primer 59 att gta gcc aac att
tgt ccg aac agc 39 to produce the chimeric construct containing domain D1 of
b2a fused to domain D2 to D5 of b1a. Primers (10 pmol each), 20 pmol
dNTPs, 20 ng T7-pSG5-b1a template, and 0.5 ml Taq polymerase (Promega,
Madison, WI) were combined and cycled at 958C for 5 min then 958C for 2
min, 558C for 1 min and 728C for 1 min for 30 cycles ending with 10 min at
728C. The PCR product was cloned into pCR 2.1 TA vector (Stratagene).




This construct contains amino acids 1–325 of b1a cDNA fused to the
N-terminus of amino acids 287–604 of b2a cDNA and was made by two
rounds of PCR. In the first round, the b1a cDNA fragment was amplified by
the forward primer 59 caa gac tag cgt gag cag tgt cac c 39 (A) encoding
residues 240–247 of b1a and the reverse primer 59 gtg ttg gat ctt tct atg acg
gag cgt ttg 39 (B), which encodes residues 321–325 of b1a and residues
287–292 of b2a. The b2a cDNA fragment was amplified by the forward
primer 59 ata gaa aga tcc aac aca agg tcg agc 39 (C) encoding residues 287–
295 of b2a and the reverse primer 59 aag ctg caa taa aca agt tct gc 39 (D)
which is homologous to the pSG5-T7 vector sequence. The first two PCR
products were mixed after purification with QIAquick PCR purification
columns (QIAGEN, Valencia, CA), and were annealed and extended by Taq
polymerase in the absence of primers (958C for 2 min, then 958C for 1 min,
438C for 1 min, and 728C for 1 min for 5 cycles). Afterward, primers A and
D were added to the PCRmixture and the reaction was continued at 958C for
1 min, 658C for 1 min, and then 728C for 1 min for 25 cycles ending with 10
min at 728C. The final PCR product was subcloned into pCR 2.1 TA vector
(Stratagene). This cDNA was then inserted into the T7-b1a-pSG5 vector via
unique PmlI and NotI sites.
Chimeric b2aC3,4SD1–3b1aD4,5
(b2a C3,4S 1–287/b1a 325–524)
This construct contains amino acids 1–287 of b2a fused to the N-terminus of
amino acids 325–524 of b1a with cysteines substituted for serines at
positions three and four of b2a. Forward primer 59 acc ggt gga cag caa atg
gta tgc agt cct ccg ggc 39and reverse primer 59 cat atc tgt gac ctc ata cc 39
were used to introduce nucleotides for serines at residue positions three and
four in the chimeric b2a 1–287/b1a 325–524 template. Primers (10 pmol
each), 20 pmol dNTPs, 20 ng T7-pSG5-b2a template, and 0.5 ml Taq
polymerase (Promega, Madison, WI) were combined and cycled at 958C for
5 min then 958C for 2 min, 558C for 1 min and 728C for 1 min for 30 cycles
finishing with 10 min at 728C. The PCR product was cloned into pCR 2.1
TA vector (Stratagene). This cDNA was then inserted into T7-b2a 1–287/
b1a 325–524-pSG5 vector via unique AgeI and Acc65I sites.
Chimeric CD8-b2a C3,4S
This construct was described previously (Restituo et al., 2000). Residues
1–209 of the human CD8A surface glycoprotein (accession number
NM_001768) were fused in-frame to the N-terminus of b2a C3S,C4S in
expression vector pcDNA3 (Invitrogen, Carlsbad, CA). The N-terminus of
CD8 has an external epitope recognized by anti-CD8 monoclonal antibody
5C2 adsorbed on polystyrene Dynabeads M-450 (Dynal).
Sequence alignment
Alignment of mouse b1a (NM_031173) and rat b2a (M80545) peptide
sequences was performed with DNASTAR (Madison, WI) using the Jotun
Hein method and an identity residue weight table. Other alignment methods
and residue weight tables also produced similar results. Based on this
alignment, domain D1 corresponds to residues 1–57 of b1a and residues
1–16 of b2a with a similarity of 41.2%; D2 corresponds to residues 58–198
ofb1a and residues 17–157ofb2awith a similarity of 78.2%;D3 corresponds
to residues 199–253 of b1a and residues 158–205 of b2a with a similarity of
36.7%; D4 corresponds to residues 254–477 of b1a and residues 206–429 of
b2a with a similarity of 90.6%; and D5 corresponds to residues 478–524
of b1a and residues 430–604 of b2a with a similarity of 21.7%.
Whole-cell voltage-clamp
Cells were voltage-clamped 3–5 days after transfection. Transfected cells
revealed by CD8 beads were voltage-clamped with an Axopatch 200B
amplifier (Axon Instruments, Foster City, CA) and a Digidata 1200 (Axon
Instruments) pulse generator and digitizer. Linear capacitance, leak currents,
and effective series resistance were compensated with the amplifier circuit.
The charge movement protocol included a long pre-pulse to eliminate
immobilization-sensitive gating currents. Voltage was stepped from
a holding potential of 80 mV to 30 mV for 700 ms, then to 50 mV
for 5 ms, then to the test potential for 50 ms, then to50 mV for 30 ms, then
to 80 mV. Test potentials were applied in decreasing order every 10 mV
from þ100 or þ110 mV to 70 mV. The intertest pulse period was 10 s.
Subtraction of the linear charge was done online with a P/4 procedure. The
P/4 pulses were delivered immediately before the protocol from 80 mV in
the negative direction. The P/4 pulses adequately subtracted the linear
component of the charging current, in the range of 80 to 120 mV. In this
range, the membrane capacity varied linearly with voltage, within a 0.5%
error.
Solutions
The external solution in all cases was (in mM) 130 TEA methanesulfonate,
10 CaCl2, 1 MgCl2, 10 HEPES titrated with TEA(OH) to pH 7.4. For Ca2þ
currents, the pipette solution was (in mM) 140 Csþ-aspartate, 5 MgCl2,
5 EGTA, and 10 MOPS-CsOH, pH 7.2. For charge movements, the pipette
solution was (in mM) 120 NMG (N-methyl glucamine)-glutamate, 10
HEPES-NMG, 10 EGTA-NMG, pH 7.3 (Ahern et al., 2001b). For charge
movements, the external solution was supplemented with 0.5 mM CdCl2,
0.5 mM LaCl3, and 0.05 mM TTX to block residual Naþ current. For Ca2þ
transients, the pipette solution was (in mM) 140 Csþ-aspartate, 5 MgCl2, 0.1
EGTA, and 10 MOPS-CsOH, pH 7.2.
Confocal ﬂuorescence microscopy
Confocal line scan measurements were performed as described previously
(Conklin et al., 1999). Cells were loaded with 4 mM fluo-4 acetoxymethyl
(AM) ester (Molecular Probes, Eugene, OR) for 60 min at room temperature.
All experiments were performed at room temperature. Cells were viewed
with an inverted Olympus microscope with a 203 objective (N.A. ¼ 0.4)
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and an Olympus Fluoview confocal attachment (Melville, NY). A 488 nm
spectrum line for fluo-4 excitation was provided by a 5 mW Argon laser
attenuated to 20% with neutral density filters. Line scans consisted of 1,000
lines, each of 512 pixels, acquired at a rate of 2.05 ms per line. Line scans
were synchronized to start 100 ms before the onset of the depolarization. The
time course of the space-averaged fluorescence intensity change was
estimated as follows. The pixel intensity was transformed into arbitrary
units, and the mean intensity was obtained by averaging pixels covering the
cell exclusively. The mean resting fluorescence intensity, Fo, corresponds to
the mean intensity of each line in the line scan averaged over the first 100 ms
before stimulation. The change in mean intensity above rest, DF, was
obtained by subtraction of Fo from the mean intensity of each line in the line
scan. DF for each line in a line scan was divided by Fo and the ratio DF/Fo
was plotted as a function of time. To construct peak Ca2þ fluorescence
versus voltage curves, we used the highest DF/Fo line value after the onset of
the pulse and up to the termination of the pulse. Image analysis was
performed with NIH Image software (National Institutes of Health,
Bethesda, MD). To obtain reliable Ca2þ transient versus voltage curves,
seven step depolarizations of 50 ms were applied in descending order (from
þ90 mV to 30 mV) from a holding potential of 40 mV. Between each
depolarization, the cell was maintained at the resting potential for 30 s to
permit recovery of the resting fluorescence.
Curve ﬁtting
The voltage dependence of charge movements (Q), Ca2þ conductance (G),
and peak fluorescence DF/Fo was fitted according to a Boltzmann
distribution (Eq. 1), namely A ¼ Amax/(1þexp((VV1/2)/k), where
Amax is Qmax, Gmax, or DF/Fo max; V1/2 is the potential at which A ¼
Amax/2; and k is the slope factor. The statistic of Boltzmann parameters
(Amax, V1/2, k) were obtained by fitting curves to individual cells and are
shown in Tables 1 and 2. The figures show the fit of the mean Amax of all
cells with the number of cells shown in Tables 1 and 2. The statistical
analyses were performed with Analyse-it software (Analyse-It Software,
Leeds, UK).
RESULTS
Studies were conducted in cultured myotubes from E18
fetuses that were either null for the DHPR b1 gene, the RyR1
gene, or both genes. To generate double null mice, we
interbred mice heterozygous of the b1 KO allele (b1WT/KO,
Gregg et al., 1996) with mice heterozygous for the RyR1 KO
allele (RyR1WT/KO, Nakai et al., 1996). Double heterozygous
F1 mice (b1WT/KO RyR1WT/KO) were phenotypically normal
and, when interbred, generated an F2 progeny consisting of
normal and paralytic fetuses. At E18, F2 fetuses with a b1
KO or RyR1 KO phenotype were identified by the absence
of movement when prodded and by the curved features of the
spine reported previously (Gregg et al., 1996; Nakai et al.,
1996). Paralytic F2 fetuses were each separately processed
for myotube cell culture while a PCR screen was conducted
in parallel. Fig. 1 shows the genotype of three paralytic
littermates (lanes 1, 2, and 3) and a parent (lane 4) screened
for the wild-type (WT) and knock-out (KO) alleles of the two
genes. A b1/RyR1 KO was identified in lane 1 based on the
amplification of DNA fragments from both KO alleles but
not from the WT alleles. Lane 2 shows a b1 KO (b1KO/KO)
heterozygous for the RyR1 allele (RyR1WT/KO), while lane 3
shows the genotype of a RyR1 KO (RyR1KO/KO) heterozy-
gous of the b1 KO allele (b1WT/KO). From a total of 102
paralytic E18 fetuses, we identified a total of 11 b1/RyR1
KO fetuses, which amounts to 1 double KO in 9.23 paralytic
littermates. This result was consistent with the predicted
odds of 1 b1/RyR1 KO out of 7 paralytic littermates from an
F2 progeny, assuming independent allele segregation. In the
TABLE 1 Ca21 conductance and charge movements of myotubes expressing b1a or b2a
G-V curve Q-V curve
Gmax (pS/pF) V1/2 (mV) k (mV) Qmax (fC/pF) V1/2 (mV) k (mV)
b1/RyR1 KO — — — 1.1 6 0.2 6.6 6 6 16.3 6 1.6
NT (10) (6)
b1a 33.7 6 7.3 17.6 6 1.5 6.3 6 0.6 3.3 6 0.4a 14.3 6 4 16.7 6 1.7
(6) (6)
b2a 115 6 18.2b 11.9 6 3.8 5.8 6 0.5 2.3 6 0.4a 18.9 6 2.8 14.6 6 0.9
(7) (5)
RyR1 KO 37.1 6 5.2 12.4 6 2.4 6.3 6 0.3 3.9 6 0.4 15.7 6 3.2 16.6 6 0.8
NT (14) (13)
b1a 35.5 6 9.9 9.9 6 3.7 5.4 6 0.3 3.4 6 0.1 20.5 6 3.7 26.1 6 1.4a
(10) (5)
b2a 195.4 6 16a 10.8 6 1.3 4.9 6 0.2 2.9 6 0.6 12.8 6 3.4 18.2 6 1.4
(15) (6)
b1KO — — — 1.9 6 0.3 1.1 6 2.4 15.8 6 1.8
NT (15) (5)
b1a 158 6 21.4 0.4 6 2.6 4.6 6 0.5 4.2 6 0.7a 24.7 6 5.2a 20.1 6 1.9
(7) (4)
b2a 170 6 14.1 13.6 6 1b 4.6 6 0.4 3.5 6 0.6 15.4 6 7.8a 19.0 6 1.7
(11) (8)
Entries correspond to mean 6 SE of Boltzmann parameters fitted to each cell according to Eq. 1. The number of cells is in parentheses. Indicated are
parameters of nontransfected (NT), wild-type b1a- and wild-type b2a- transfected myotubes with genotypes b1/RyR1 KO, RyR1 KO, and b1 KO. a indicates
parameters compared to NT of each genotype (with the exception of conductance parameters of b1 KO and b1/RyR1 KO) with t-test significance p\ 0.05.
For conductance parameters of b1 KO and b1/RyR1 KO myotubes, b indicates data of b1a-transfected compared to b2a-transfected myotubes with t-test
significance p\ 0.05.
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text and figures, b1/RyR1 KO, b1 KO, and RyR1 KO
identify the genotype b1KO/KO RyR1KO/KO, b1KO/KO
RyR1WT/WT, and b1WT/WT RyR1KO/KO, respectively.
b1/RyR1 KO myotubes were cultured and transfected
with either the endogenous isoform b1a or rat b2a, which,
among many tested b variants from the four gene families
(described below), had the unique ability to stimulate Ca2þ
current expression in the absence of RyR1. Fig. 2 shows
Ca2þ currents expressed by the two isoforms in b1/RyR1
KO, RyR1 KO, and b1 KO myotubes. The data correspond
to whole-cell Ca2þ currents elicited by 500-ms depolariza-
tions to 10, þ10, and þ30 mV from a holding potential of
40 mV. Conductance versus voltage relationships are
shown immediately below the Ca2þ currents for the three
transfection conditions, namely nontransfected (gray sym-
bols), b1a-transfected (white symbols), or b2a-transfected
(black symbols). The complete pulse protocol utilized for
fitting conductance versus voltage curves consisted of step
depolarizations from 35 mV to þ60 mV every 5 mV. We
found that nontransfected (labeled NT) b1/RyR1 KO and
b1 KO myotubes had no detectable Ca2þ currents. In our
hands, the limit of Ca2þ current detection was ;20 pA/cell.
A background Ca2þ current of low density was previously
reported in intercostal muscle fibers dissociated from E18
b1 KO fetuses (Strube et al., 1996). However, this current
component was far less frequent in cell cultures of limb
myotubes (Strube et al., 1998) and was entirely absent here.
The null background could possibly be related to changes in
the genetic background because the colony was constantly
regenerated by outbred mice to avoid a reduction of the litter
size. If b1/RyR1 KO myotubes are null for both genes,
overexpression of the missing b1a subunit should restore the
phenotype of the RyR1 KO myotube. In b1a-expressing b1/
RyR1 KO myotubes, we consistently detected a low-density
Ca2þ current with an average Gmax of 346 7 pS/pF (n ¼ 6)
shown in the left column of Fig. 2. This density was similar
to that of nontransfected RyR1 KO myotubes shown in the
center column of Fig. 2 (37 6 5 pS/pF, n ¼ 14). Thus, b1a
overexpression in the double KO recovered the RyR1 KO
phenotype, and furthermore, the Ca2þ current density of
RyR1 KO myotubes was similar to that in previous reports
(Avila and Dirksen, 2000; Ahern et al., 2001b). Averages of
Boltzmann parameters fitted to the conductance versus
voltage curve of each cell and the statistical significance of
the data are shown in Table 1. b1a overexpression in RyR1
KO and b1 KO myotubes is shown in the center and right
columns of Fig. 2. We found that b1a failed to increase the
Ca2þ current density of the RyR1 KO myotube but
recovered an entirely normal (WT) density in the b1 KO
myotube. In the latter case, the Gmax was 158 6 21 pS/pF
TABLE 2 Ca21 conductance of myotubes expressing DHPR b-chimeras
RyR1 KO b1 KO
Gmax (pS/pF) V1/2 (mV) k (mV) Gmax (pS/pF) V1/2 (mV) k (mV)
b2a C3,4S 59.8 6 3.9a 18.6 6 2.1a 6 6 0.3 166.4 6 17.9 15.2 6 2.3 4.1 6 0.4
(12) (6)
CD8-b2a C3,4S 161 6 16.7 22 6 1.3a 6 6 0.5 195.8 6 12.7 20.9 6 0.5b 5.3 6 0.3
(8) (6)
b1a Q3C, K4C 49 6 4.6a 28.1 6 3.5a 6.1 6 0.4 237.8 6 8.8b 30 6 1.4b 6.5 6 0.4b
(6) (8)
b2aD1 b1a D2–5 55.1 6 4.5a 25.3 6 2.5a 4.1 6 0.6 232.8 6 14.6 22.8 6 1.3b 4.8 6 0.5
(5) (5)
b2aD1–3 b1a D4,5 173.4 6 14 9.2 6 2.4 4.3 6 0.6 225.7 6 22.4 11.5 6 2.6 4.2 6 0.5
(7) (6)
b2aC3,4S D1–3 b1a D4,5 64.5 6 7.3a 23.9 6 1.4a 6.6 6 0.5a 230 6 30 13.3 6 1.8 4.4 6 0.4
(8) (5)
Entries correspond to mean 6 SE of Boltzmann parameters fitted to each cell according to Eq. 1. The number of cells is in parentheses. Constructs were
expressed in either RyR1 KO myotubes or b1 KO myotubes. a and b indicate parameters with ANOVA significance p\0.05 compared to Ca2þ conductance
parameters of wild-type b2a in RyR 1 KO (a) or b1 KO (b) myotubes. Parameters of b2a expression are shown in Table 1.
FIGURE 1 Genotype of b1/RyR1 KO mice obtained by PCR. DNA
fragments amplified with genotype-specific primers are shown on two
separate 3% agarose gels. Each gel shows two sets of PCR reactions, each for
a specific allele (top: RyR1 KO, RyR1 WT; bottom: b1 KO, b1 WT).
Indicated on the left are three size markers (500, 200, and 100 bp) of a total
of six markers run in each gel. Indicated by arrows are the expected sizes of
the amplified DNA for each reaction. Templates used were total DNA of
three paralytic littermates (lanes 1–3), a double heterozygous parent (lane 4),
and a control reaction without template (lane 5).
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(n ¼ 7) and was consistent with previous reports from our
laboratory (Beurg et al., 1997; 1999a,b). The positive result
in the b1 KO myotube indicated that the expression vector
and transfection procedures were adequate for Ca2þ current
expression. Therefore, the low functional expression in the
b1/RyR1 KO and RyR1 KO myotubes were likely due to the
specific absence of RyR1. Additionally, the studies with b1a
validated the genotype of the double KO myotube entirely. If
myotubes assigned as b1/RyR1 KO were in fact b1 KO but
RyR1WT/WT, b1a overexpression in the misidentified b1/
RyR1 KO myotubes should have rescued a high-density
Ca2þ current similar to that seen by b1a overexpression in
b1 KO myotubes (Fig. 2, right column). However, this was
not the case. If, on the other hand, myotubes assigned as b1/
RyR1 KO were in fact RyR1 KO but b1WT/WT, the low-
density Ca2þ current of ;30 pS/pF present in RyR1 KO
myotubes (Fig. 2, center column) should have been observed
in the nontransfected misidentified b1/RyR1 KO myotubes.
Again, this was not the case.
Overexpression of b2a in the b1 KO myotube was shown
previously to restore the L-type Ca2þ current (Beurg et al.,
1999a,b). We therefore became interested in determining if
a hybrid DHPR containing b2a could be kept under
retrograde control by RyR1. If this was the case, b2a should
not restore high-density Ca2þ currents in the absence of
RyR1. The right column of Fig. 2 confirmed the previous
result showing that b2a can readily replace b1a and express
a high-density Ca2þ current in the b1 KO myotube. In b1/
RyR1 KO and RyR1 KO myotubes, b2a recovered Ca2þ
currents with a density four- to sixfold larger than those
recovered by b1a (Fig. 2 left and center columns). The result
in the RyR1 KO myotube was particularly compelling
because the maximal Ca2þ conductance stimulated by b2a,
after discounting the Ca2þ conductance of the nontransfected
myotube, was approximately the same as in the b2a-
expressing b1 KO myotube. Thus, Ca2þ currents recovered
by b2a had readily bypassed the inhibition imposed by the
absence of RyR1. Moreover, the presence of b1a in the
RyR1 KOmyotube did not interfere with the ability of b2a to
bypass current inhibition. We noticed that the maximal Ca2þ
conductance recovered by b2a was lower in b1/RyR1 KO
than in RyR1 KO myotubes. To understand this situation
better, we compared the Ca2þ conductance of the b2a-
expressing double KO myotube to that of the double KO
myotube reconstituted with the two missing homologous
subunits. The Gmax generated by the combined expression
of b1a and RyR1 in b1/RyR1 KO myotubes was 122 6 22
pS/pF (n ¼ 5), and this value was not significantly different
from that of b2a-expressing b1/RyR1 KO myotubes (1156
18 pS/pF, n ¼ 7; t-test significance p ¼ 0.84). However, it
was of significance to note that the Gmax of double KO
myotubes expressing b1a and RyR1 was lower than the
Gmax of the b1a-expressing b1 KO myotube (1586 21 pS/
pF, n ¼ 7) and the RyR1-expressing RyR1 KO myotube
(177 6 32 pS/pF, n ¼ 6). In our hands, Ca2þ current
recovery to levels present in wild-type myotubes required
cDNA expression for 3–5 days when either RyR1 was
expressed in the RyR1 KO myotube or b1a was expressed in
the b1 KOmyotube. This result agreed with a previous study
of RyR1 expression in the RyR1 KO myotube where the
post-transfection time required for Ca2þ current recovery
was 3 to 6 days (Avila et al., 2001). It could be that the
combined absence of both genes in double KO myotubes
resulted in structural changes and/or changes in protein
FIGURE 2 DHPR Ca2þ currents in b1/
RyR1 KO, RyR1 KO, and b1 KO myotubes.
Ca2þ currents are shown in response to 500-ms
voltage steps to 10, þ10, and þ30 mV from
a holding potential of40 mV. Nontransfected
(NT), b1a-expressing, or b2a-expressing my-
otubes are shown in the top, middle and bottom
rows, respectively. Scale bars are 1 nA and 200
ms. The graphs show the voltage dependence
of the Ca2þ conductance calculated from the
maximal current during the pulse and the
reversal potential obtained by extrapolation.
Symbols show the mean Ca2þ conductance
density (6 SE) for the number of cells
indicated in Table 1. The mean was fitted
according to Eq. 1. The parameters of the fit
with Gmax in pS/pF, V1/2 in mV, and k in mV
are as indicated below. For b1/RyR1 KO
myotubes 29.8, 14.8, 7.4 for b1a-transfected;
and 114.8, 9.7, 7.5 for b2a-transfected. For
RyR1 KO myotubes 37.8, 15.0, 8.6 for NT;
35.8, 7.1, 7.1 for b1a-transfected; and 196.7,
10.8, 5.1 for b2a-transfected. For b1 KO
myotubes 156.6,0.3, 4.9 for b1a-transfected;
and 174.8, 7.5, 5.3 for b2a-transfected.
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expression patterns in the nascent myotube, which are not
easily reverted by post-addition of the missing cDNAs for
3–5 days. Presumably, longer expression times might be
required in this case for full Ca2þ current recovery. However,
the extensive growth of myotubes after the first week of
cDNA expression and the inadmissibly high series resistance
of myotubes kept in culture after 5 days precluded us from
further investigating this possibility.
A higher Ca2þ current density recovered by b2a compared
to b1a could reflect a better ability of b2a to traffic the DHPR
to the cell surface. To determine if this was the case, we used
gating currents to gauge the membrane density of DHPR
voltage sensors. We have previously shown that a pore-
forming DHPR generates as much gating current as a non
pore-forming DHPR (Ahern et al., 2001a). Thus, the
technique is impervious to the functional state of the Ca2þ
channel, which is an important consideration in the present
case. Fig. 3 shows intramembrane currents produced by the
movement of charges in the expressed DHPR in response to
4 of 17 step voltages delivered to each cell (30, þ10, þ50,
and þ90 mV) from a holding potential of 80 mV. The
protocol included a 700-ms pre-test pulse depolarization to
30 mV to remove immobilization sensitive components of
the gating current unrelated to the DHPR and pre-test P/4
pulses to eliminate linear components unrelated to voltage
sensors. We found a good correspondence between the
magnitude of the ON and OFF components, as would be
expected if charge movements were due to reversible
displacements of intramembrane charges. The graphs at the
bottom of each column in Fig. 3 show charge versus voltage
relationships for nontransfected and b1a- and b2a-express-
ing myotubes. The immobilization-resistant charge was
obtained by integration of the OFF component which, in
our hands, was less contaminated by ionic current than the
ON component. The main contaminant of the ON compo-
nent was a nonlinear outward current, presumably from a Kþ
channel, that was not always blocked by the pipette solution.
In all cases, the OFF charge increased in a sigmoidal fashion
starting at approximately10 mV and saturated at potentials
more positive than þ60 mV, and data were adequately fit by
a Boltzmann equation (Eq. 1) shown by the lines. In the b1/
RyR1 KO myotube (Fig. 3, left column), we detected a small
background charge with a maximal density of ;1 fC/pF.
Overexpression in these cells of b1a or b2a increased the
maximal charge density threefold and twofold, respectively,
and this difference was significant in each case (see Table 1).
Thus, contrary to expectations based on Ca2þ current
densities, the density of DHPR voltage sensors was lower
in b2a-expressing than in b1a-expressing double KO
myotubes. Overexpression of b1a in the double KOmyotube
reconstituted quantitatively the density of DHPR voltage
sensors present in the nontransfected RyR1 KO myotube.
This can be seen by comparing the charge versus voltage
curves at the bottom of Fig. 3 (left plot open symbols versus
center plot gray symbols) and the statistic of the Boltzmann
parameters presented in Table 1. The Qmax of b1a-
expressing b1/RyR1 KO myotubes was 3.3 6 0.4 fC/pF,
whereas the Qmax of nontransfected RyR1 KO myotubes
was 3.96 0.4 fC/pF, with the latter result in agreement with
previous determinations (Avila and Dirksen, 2000). In-
terestingly, neither overexpression of b1a nor b2a rescued
additional charge in the RyR1 KO myotube. b2a caused
FIGURE 3 DHPR charge movements in b1/
RyR1 KO, RyR1 KO, and b1 KO myotubes.
Intramembrane currents are shown in response
to 50-ms voltage steps to 30, þ10, þ50, and
þ90 mV from a holding potential of 80 mV.
Nontransfected (NT), b1a-expressing, or b2a-
expressing myotubes are shown in the top,
middle, and bottom rows, respectively. Scale
bars are 0.5 nA and 25 ms. The graphs show the
voltage dependence of the intramembrane
charge obtained by integration of the OFF
current. Symbols show the mean nonlinear
charge density (6 SE) for the number of cells
indicated in Table 1. The lines are a fit of the
mean according to Eq. 1. The parameters of the
fit with Qmax in fC/pF, V1/2 in mV, and k in
mV are: for b1/RyR1 KO myotubes 1.3, 18.5,
16.6 for NT; 3.1, 15.1, 17.3 for b1a-transfected;
and 2.2, 16.7, 17.2 for b2a-transfected. For
RyR1 KOmyotubes 3.8, 16.2, 17.8 for NT; 3.4,
16.3, 23.4 for b1a-transfected; and 2.5, 12.1,
19.4 for b2a-transfected. For b1 KO myotubes
2.0, 1.6, 19.2 for NT; 4.6, 25.7, 19.2 for b1a-
transfected; and 3.4, 15.6, 19.5 for b2a-trans-
fected.
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a slight reduction in Qmax relative to the nontransfected
background, although this difference was not significant.
The same pattern of charge recovery observed in the double
KO was repeated in the b1 KO myotube (Fig. 3, right
column). The maximal charge density in the b1a-expressing
b1 KO myotube was higher than in b2a-expressing myo-
tubes. However, due to the background charge present in
nontransfected cells, the charge expressed by b1a, but not
that by b2a, was significantly different from background (see
Table 1). TheQmax of nontransfected b1 KO myotubes was
;twofold higher than the Qmax of the b1/RyR1 KO
myotube or that of the a1S-null dysgenic myotube (Ahern et
al., 2001a). Such excess of charges is likely to arise from
a low density of b1-less DHPR complexes transported to the
surface, perhaps by residual levels of other beta isoforms
present in the skeletal myotube. In summary, the intra-
membrane charge movement analyses did not provide
evidence for a differential ability of b2a to promote transport
and targeting of the DHPR to the cell surface. On the
contrary, b2a was less effective than b1a in all three
myotube genotypes analyzed.
Evidence in favor of a direct interaction of the b2a isoform
with the a1S pore subunit was obtained from the kinetics of
activation of the expressed Ca2þ current. Previous studies in
oocytes had shown that b2a is unique among splice variants
of the four genes in that it reduced the rate of Ca2þ current
inactivation of neuronal a1E channels, whereas all other
variants had the opposite effect (Olcese et al., 1994; Qin
et al., 1998). Here, we could not investigate the inactiva-
tion rate because the Ca2þ current of cultured myotubes
inactivates very slowly, and in b1a-expressing b1 KO
myotubes, the current is;10% inactivated at the end of a 1-s
depolarization (Beurg et al., 1997). Longer pulses had
deleterious effects on the pipette seal and, for that reason,
were not attempted. Nevertheless, we found that b2a reduced
the activation rate, which, to our knowledge, had not been
documented previously for this variant. We investigated the
activation kinetics in response to depolarizations of 500 ms,
of which we omitted the first 10 ms due to incomplete
compensation of the capacitative transient and fitted the
remaining 490 ms as a first- or second-order process. Fig. 4
shows normalized whole-cell Ca2þ current (gray traces)
during a depolarization to þ30 mV from a holding potential
of 40 mV in b1a- and b2a-expressing b1 KO myotubes.
FIGURE 4 Kinetics of activation of Ca2þ
currents in b1 KO myotubes expressing b1a or
b2a. A, B) Ca2þ currents (gray line) were
normalized according to the maximal current
during the pulse. They were obtained in b1 KO
myotubes transfected with b1a (top) or b2a
(bottom) in response to a 500-ms voltage step
to þ30 mV from a holding potential of 40
mV. Scale bar is 100 ms. To fit the current
during the pulse, the first 10 ms after the onset
of the pulse was omitted. A) shows a mono-
exponential fit and B) shows a biexponential fit
of the same data, with the fit indicated by the
black line. Time constants of the monoexpo-
nential fit are 58.4 ms for b1a and 103.4 ms for
b2a. Time constants of the biexponential fit are
7, 62.5 ms for b1a and 16.9, 119.2 ms for b2a.
Relative contributions of the fast and slow
components are 0.11, 0.89 for b1a and 0.15,
0.85 for b2a. Chi-square tests of the fit were as
follows: x2 ¼ 0.026 for monexponential and
x2 ¼ 0.00024 for biexponential fits of b1a; x2
¼ 0.028 for monoexponential and x2¼ 0.0006
for biexponential fits of b2a. C) Voltage
dependence of the single activation time
constant obtained from the monoexponential
fit of Ca2þ currents. Unpaired t-tests revealed
no significant differences in a comparison
of b1a (empty symbols) versus b2a ( ﬁlled
symbols) at any voltage. D) Voltage depen-
dence of the activation time constants obtained
from the biexponential fit of the same data.
Unpaired t-test revealed significance differ-
ences (p\0.05) for t slow at 5, 0,þ5, þ10,
andþ15 mV, and t fast atþ15,þ20,þ25, and
þ30 mV.
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Based on a fit of the entire pulse current during a 1-second
depolarization, we had previously concluded that the
activation kinetics of the Ca2þ current in b1a-expressing
b1 KO myotubes followed a monoexponential time course
(Beurg et al., 1997). However, at a higher temporal
resolution, we noticed that the early phase of the Ca2þ
current activated faster than predicted by a monoexponential
fit. Mono- and biexponential fits of the same data are shown
by Figs. 4 A and 4 B, respectively. The biexponential fit was
adequate to account for the fast-activating component, and
the comparatively slower component evident at 100 ms or
longer. A chi-square test (see the figure legend) confirmed
the visual inspection. Furthermore, the voltage dependence
of the activation time constant favored the biexponential
representation. In the case of the monoexponential fit, the
activation time constant increased with voltage, which would
be unusual for a voltage gated channel. In contrast,
t(activation) for the slow and fast processes identified by
the biexponential fit was essentially independent of voltage
in the range of potentials investigated. Such a weak voltage
dependence agreed with the activation kinetics reported in
normal myotubes in the same range of potentials and at the
same external Ca2þ concentration (Dirksen and Beam,
1995). Furthermore, Ca2þ current activation was previously
reported to be a biexponential process in a1S-expressing
dysgenic myotubes (Ahern et al., 2001b) and RyR1-
expressing RyR1 KO myotubes (Avila and Dirksen, 2000).
For all these reasons, we are confident that a biexponential
representation of the data provides a more accurate de-
scription of the activation process. Fig. 5 A shows
biexponential fits of normalized Ca2þ currents at the same
potential recovered by b2a in the three myotube genotypes.
For comparison, the figure also shows the fitted time course
of the normal L-type Ca2þ current and the Ca2þ current of
RyR1 KO and RyR1-expressing RyR1 KO myotubes. In
agreement with previous results, the Ca2þ current of RyR1
KO myotubes activated faster than the normal Ca2þ current
or that of RyR1-expressing RyR1 KO myotubes (Avila and
Dirksen, 2000). In contrast, Ca2þ currents obtained by
overexpression of b2a activated significantly slower in both
the absence and the presence of RyR1. The slowing of the
activation kinetics was manifested in the two components of
activation (Fig. 5 C) and occurred without a change in the
relative proportions of the two components (Fig. 5 D). The
statistical analysis (see the figure legend) demonstrated that
t(slow) and t(fast) were indistinguishable among the b2a-
expressing b1/RyR1 KO, RyR1 KO, and b1 KO myotubes
and were significantly larger than in RyR1 KO and RyR1-
expressing RyR1 KO myotubes. Hence, the kinetics of
activation of the b2a-mediated Ca2þ current had the unique
feature of being noticeably slow and, in addition, was
impervious to the presence or absence of RyR1. The kinetic
FIGURE 5 Kinetics of activation of Ca2þ
currents expressed by b2a in the absence and
presence of RyR1. A) Normalized Ca2þ
currents (gray) are shown in response to
a 500-ms depolarization to þ30 mV from
a holding potential of 40 mV. Scale bar is
100 ms. The first 10 ms after the onset of the
pulse was omitted, and the remainder of the
pulse current was fit as a biexponential in all
cases (black line). The top row shows the fit of
the pulse current in normal (WT), RyR1 KO,
and RyR1-expressing RyR1 KO myotubes.
The bottom row shows the fit in b2a-express-
ing b1/RyR1 KO, RyR1 KO, and b1 KO
myotubes. t fast and t slow are 8.6, 74.5; 4.3,
34.3; 6.1, 70.2; 16.3, 112.9; 16.3, 110.3; 16.9,
119.2 ms, respectively, from left to right with
top row first. Relative contributions of fast and
slow components are 0.24, 0.76; 0.26, 0.74;
0.28, 0.72; 0.16, 0.84; 0.20, 0.80; 0.15, 0.85,
respectively, in the same order. B) The mean
(þ1 SE) t fast and t slow at þ30 mV is shown
for the genotypes analyzed above. The last
three entries correspond to myotubes express-
ing b2a. The number of fitted Ca2þ currents,
each from a separate myotube, included in the
averages was 7 (WT), 10 (RyR1 KO), 10
(RyR1 KO þ RyR1), 5 (b1/RyR1 KO þ b2a),
10 (RyR1 KO þ b2a), and 8 (b1 KO þ b2a).
One-way ANOVA showed no significant difference for t fast (p¼ 0.75) or t slow (p¼ 0.27) of b2a-expressing myotubes. All other entries were significantly
different from b2a-expressing myotubes (p\0.001). C) The mean (þ1 SE) contribution of the fast and slow components of the biexponential fit is shown for
all genotypes analyzed. One-way ANOVA revealed no significant differences between fast and slow components analyzed separately.
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analysis indicated that b2a could pair up with a1S and
conferred unique activation kinetics to the skeletal DHPR
Ca2þ channel.
The molecular determinants of the b2a subunit responsi-
ble for Ca2þ current expression in the absence of RyR1 were
pursued by screening variants of the four b-genes in RyR1
KO myotubes. Fig. 6 shows the maximal Ca2þ conductance
of RyR1 KO myotubes overexpressing the indicated b-iso-
forms, all of which were subcloned in the mammalian
expression vector pSG5. The b1b and b4 variants, which
have abundant expression in the brain (Powers et al., 1992;
Burgess et al., 1999), failed to recruit Ca2þ current above the
endogenous level observed in nontransfected cells. Like-
wise, the b3 variant, which has a broader pattern of tissue
expression (Castellano et al., 1993a), was also unable to
recruit Ca2þ current. Thus, b2a was unique in its ability to
stimulate Ca2þ current expression, and, as shown in Fig. 6, it
stimulated Gmax ;5-fold. Such stimulatory effect required
the N-terminus half of b2a, as demonstrated by the large
Gmax generated by the b2a-b1a chimera consisting of b2a
domains D1, D2, and D3 and b1a domains D4 and D5.
However, the reversed b1a-b2a chimera, consisting of b1a
domains D1, D2, and D3 and b2a domains D4 and D5, failed
to rescue Ca2þ current. We further asked whether a domain
of the b1a subunit could be involved in inhibition of Ca2þ
current expression in the RyR1 KO myotube. Elimination of
this sequence might result in Ca2þ current reexpression when
RyR1 was not present. To address this possibility, we in-
vestigated the involvement of the b1-specific D1, D3, and
D5 domains. Neither deletion of domain D1 of b1a (b1aD1–
57) nor domain D5 (b1aD490–524) had a positive effect
on Ca2þ current expression. Furthermore, the splice variant
b1c, which consists of b1a domains D1, D2, D4, and D5 and
lacks D3 domain (Powers et al., 1992), also failed to express
Ca2þ currents. We do not believe that these negative results
arise from a lack of function because b1aD1–57, b1aD490–
524, and b1c increased Ca2þ current expression in b1 KO
myotubes (Beurg et al., 1999b). Furthermore, b1b increased
Ca2þ current expression mediated by the neuronal a1A iso-
form in dysgenic myotubes (not shown), and b3 increased
Ca2þ current expression mediated by the cardiac a1C iso-
form in double a1S/b1 KO myotubes (Ahern et al., 1999).
In summary, structural determinants for Ca2þ current expres-
sion were mapped toward the N-terminus of b2a. Addi-
tionally, we did not find specific sequences associated with
inhibition of Ca2þ current, which, in principle, could have
been present in the skeletal b1a isoform and could account
for the low Ca2þ conductance and comparatively large
charge movements present in the RyR1 KO myotube.
The rat b2a variant has vicinal cysteines at N-terminal
positions three and four, which are not present in other splice
variants from the same gene nor in variants from different
b-genes (Fig. 7 A). The functional consequences of these
two cysteines of b2a have been investigated in several
expression systems and account for unique properties of
voltage-gated Ca2þ channels (Chien et al., 1996; Qin et al.,
1998; Restituto et al., 2000). Because the N-terminal half of
b2a was required for Ca2þ current expression in the RyR1
KO myotube (Fig. 6), we investigated the participation of the
double cysteine motif in this process. Following the
approach of the three studies cited above, we mutated
cysteines at positions three and four of b2a to serines and
transfected the construct in RyR1 KO myotubes. Represen-
tative Ca2þ currents from a b2a C3,4S-transfected myotube
are shown in Fig. 7 B, and the population average con-
ductance versus voltage relationship is shown in Fig. 7 D.
The Ca2þ current stimulated by b2a C3,4S was ;threefold
lower than that stimulated by wild type b2a, and was similar
in density to that of nontransfected myotubes. The Gmax in
b2a C3,4S-expressing and nontransfected RyR1 KO my-
otubes was 57 6 3.9 pS/pF (n ¼ 12 cells) and 37 6 5 pS/pF
(n ¼ 14 cells), respectively, and the difference was mildly
significant (t-test significance p ¼ 0.011). As a positive
control, b2a C3,4S was transfected in b1 KO myotubes,
which express RyR1 but do not express Ca2þ current owing
to the absence of the endogenous b-isoform (Gregg et al.,
1996). Table 2 shows that the Ca2þ conductance of b2a
C3,4S-expressing b1 KO myotubes was similar to that of
wild-type b2a-expressing b1 KO myotubes. Thus, the
FIGURE 6 Ca2þ conductance recovered by DHPR b variants in RyR1
KO myotubes. The Ca2þ conductance of RyR1 KO myotubes transfected
with the indicated b-construct was fit to Eq. 1 for the number of cells
indicated in parenthesis. The b2a-b1a chimera was b2a 1–287/b1a 325–
524. The b1a-b2a chimera was b1a 1–325/b2a 287–604. Gmax in pS/pF,
V1/2 in mV, and k in mV were: 37.2 6 5.2, 12.4 6 2.4, 6.3 6 0.3 for NT;
35.66 5.6, 9.96 3.7, 5.46 0.3 for b1a; 41.76 3.7, 18.16 2.3, 6.86 1.1
for b1b; 34.86 6.4, 236 2.4, 7.36 1.7 for b1c; 1956 16, 10.86 1.3, 4.9
6 0.2 for b2a; 39.76 6.5, 19.76 2.8, 5.86 0.5 for b3; 56.86 10.6, 26.56
2.6, 5.8 6 0.5 for b4; 36.3 6 11.5, 14.6 6 2.0, 6.3 6 0.6 for b1a D1–57;
41.36 7.6, 17.96 1.1, 6.36 0.3 for b1a D490–524; 1736 14.0, 9.36 2.4,
4.3 6 0.6 for b2a-b1a; and 38.66 8.2, 10.6 6 3.4, 5.9 6 2.2 for b1a-b2a.
Unpaired t-test showed significant differences (p \ 0.001) relative to
nontransfected for the maximal Ca2þ conductance recovered by b2a and
b2a-b1a.
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inability of b2a C3,4S to recover Ca2þ current in RyR1 KO
myotubes was due to the specific absence of the two
cysteines and not due to a generalized inability of the
construct to rescue Ca2þ channel function. Studies in
nonmuscle expression systems have shown that the b2a
variant becomes tethered to the plasma membrane by
covalent palmitoylation of the double cysteine motif (see
diagram in Fig. 7 C; Chien et al., 1996; Qin et al., 1998;
Restituto et al., 2000). Furthermore, the unique properties of
Ca2þ channels, conferred by b2a, require tethering of this
subunit to the plasma membrane (Restituto et al., 2000). To
demonstrate if a membrane tethering mechanism was
responsible for the Ca2þ current stimulation caused by b2a
in RyR1 KO myotubes, we expressed a fusion protein
consisting of a b2a subunit lacking the double cysteine motif
fused to the C-terminus of the transmembrane and extra-
cellular domains of the lymphocyte glycoprotein CD8A.
The CD8-b2a C3,4S fusion protein was previously shown
to anchor b2a to the plasma membrane of HEK cells
(Restituto et al., 2000). The N-terminus of the fusion protein
carried an external epitope recognized by micron-size beads
coated with an anti-CD8 antibody (see Materials and
Methods). Thus, expression of the fusion protein on the
surface of myotubes was recognized by incubation of
transfected myotubes with anti-CD8 beads added to the
external solution. Fig. 7 C shows a field of RyR1 KO
myotubes transfected solely with the CD8-b2a C3,4S cDNA
and incubated with anti-CD8 beads. Approximately 10% of
transfected myotubes were found to bind CD8 beads, and the
binding could not be removed by extensive washout of the
external solution. The asterisks in Fig. 7 C mark myotubes
lacking expression of the CD8 epitope. Bead-coated
myotubes were found to express high-density Ca2þ currents
in all cases (8 of 8 cells), whereas myotubes lacking ex-
pression of the CD8 epitope had Ca2þ current densities
typical of nontransfected cells (4 of 4 cells). Ca2þ currents
from a representative CD8-b2a C3,4S expressing RyR1 KO
myotube are shown in Fig. 7 B, and the population average
conductance versus voltage curve is shown in Fig. 7 D. For
comparison, the line without data in Fig. 7 D shows the
Boltzmann fit of the Ca2þ conductance of RyR1 KO
myotubes expressing wild-type b2a obtained in Fig. 2. The
FIGURE 7 Participation of a
double cysteine motif of b2a in
Ca2þ current expression in RyR1
KO myotubes. A) Comparison of
residues 1 through 14 of mouse
b1a, rat b2a, rat b3b, and rat b4.
Nonconserved cysteines at posi-
tions three and four of b2a are
underlined. B) Ca2þ current ex-
pression by a b2a variant lacking
cysteines at positions three and four
(b2a C3,4S) and by a membrane-
anchored variant CD8-b2a C3,4S
in RyR1 KO myotubes. Ca2þ
currents were elicited by 500-ms
depolarizations from a holding po-
tential of 40 mV to 10, þ10,
and þ30 mV. Scale bars are 2 nA
and 100 ms. C) Wide-field view of
RyR1 KO myotubes expressing
CD8-b2a C3,4S. Surface expres-
sion of the construct is revealed by
anti-CD8 beads added to the exter-
nal solution. Myotubes were trans-
fected with the CD8-b2a C3,4S
cDNA exclusively. Asterisk marks
nontransfected myotubes in the
same field. Bar is 50 microns and
bead diameter is 4.5 microns. Dia-
grams depict membrane-anchoring
of wild-type b2a and CD8-b2a
C3,4S according to previous stud-
ies (Chien et al., 1996; Qin et al.,
1998; Restituto et al., 2000). D)
Voltage dependence of the Ca2þ conductance in RyR1 KOmyotubes. The line without data corresponds to the voltage dependence of the Ca2þ conductance of
b2a-expressing RyR1 KOmyotubes from Fig. 2. Symbols show the mean conductance (6 SE) for the number of cells indicated in Table 2. The lines are a fit of
the mean conductance according to Eq. 1. Parameters of the fit with Gmax in pS/pF, V1/2 in mV, and k in mV are 56, 16.8, and 6.6 for b2a C3,4S (open
diamonds); and 160, 21.7, and 6.8 for CD8-b2a C3,4S ( ﬁlled diamonds).
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Ca2þ conductance density expressed by CD8-b2a C3,4S was
;threefold higher than that expressed by b2a C3,4S, and
furthermore, a cell-by-cell analysis of the data (Table 1)
indicated that the maximal Ca2þ conductance density
(Gmax) expressed by CD8-b2a C3,4S was statistically
indistinguishable from that expressed by wild-type b2a
(Table 2). This result demonstrated that membrane anchoring
of b2a via the CD8 transmembrane domain mimicked the
Ca2þ current stimulation produced by the double cysteine
motif present in wild-type b2a. Thus, it is likely that the
double cysteine motif of b2a exerted its stimulatory effect
on Ca2þ currents by a mechanism involving palmitoylation
and anchoring of the b subunit to the myotube surface
membrane.
The exeriments in Fig. 7 demonstrated that the double
cysteine motif of b2a was essential for the Ca2þ current
stimulation observed in the absence of RyR1. However, this
motif alone might not be sufficient. To determine whether
the double cysteine motif acted alone or in combination with
other domains of b2a, we transferred the N-terminal se-
quence of b2a to b1a and measured the Ca2þ conductance
expressed by these chimeras in RyR1 KOmyotubes. We first
inserted cysteines at an equivalent position in b1a. Fig. 8 A
shows that b1a Q3C, K4C was unable to stimulate Ca2þ
current expression in RyR1 KO myotubes beyond the
density present in nontransfected cells. We next replaced the
entire D1 domain of b1a by the 16-residue b2a D1 domain.
This chimera, namely b2aD1b1aD2–5, was also unable to
significantly stimulate the expression of Ca2þ current in
RyR1 KO myotubes. Finally, we replaced domains D1, D2,
and D3 of b1a by equivalent domains of b2. This chimera,
namely b2aD1–3b1aD4,5 expressed high-density Ca2þ
currents, and the Gmax expressed in RyR1 KO myotubes
was statistically indistinguishable from that of wild-type b2a
(Table 2). Because D2 domains of b1a and b2a have a 78%
similarity (see Materials and Methods), the positive results
obtained with the last chimera suggest that domains D1 and
D3 of b2a are essential for Ca2þ current expression in the
absence of RyR1, whereas b1a D2 and b2a D2 may possibly
be interchangeable. To determine if domains D1, D2, or D3
of b2a could stimulate Ca2þ currents in the absence of the
double cysteine motif, the two vicinal cysteines in the high
Ca2þ current-expressing b2aD1–3b1aD4,5 chimera were
mutated to serines. Fig. 8A shows that the Ca2þ conductance
expressed by the b2aC3,4SD1–3b1aD4,5 chimera was
drastically reduced. Elimination of the two cysteines reverted
the Gmax expressed by the latter chimera back to that seen
with b2a C3,4C (Table 2). In summary, the results with b2a-
b1a chimeras reaffirmed the critical role of C3 and C4 in
Ca2þ current stimulation. Additionally, domains D1–D3 of
b2a were required for Ca2þ current stimulation. However,
b2a D1–3 did not have an independent signaling function in
the absence of C3 and C4. It is entirely possible that critical
residues in b2a D1–3 provide a structural context essential
for anchoring the subunit to the plasma membrane or for
palmitoylation of C3 and/or C4 in the skeletal myotube. It is
important to emphasize that all chimeras recovered a simi-
larly large Gmax in the b1 KO myotube, regardless of their
conductance behavior in the RyR1 KO myotube (Table 2).
Therefore, the inability to stimulate Ca2þ current in the
RyR1 KO myotube did not imply an inability of the con-
struct to become integrated into a functional DHPR. The posi-
tive result in the b1 KO myotube indicated that molecular
determinants must be present in the DHPR, perhaps in
subunits other than b1a, for stimulation of Ca2þ current ex-
pression by RyR1.
EC coupling takes place in peripheral couplings estab-
lished between the surface membrane and the SR of cultured
myotubes (Takekura et al., 1994). The structural evidence
indicates that when RyR1 is not present, the native DHPR
forms clusters that remain colocalized in the vicinity of
peripheral couplings (Protasi et al., 1998). However, it is
entirely possible that b-variants that have the membrane
anchoring domain of b2a might divert the DHPR to other
locations on the myotube surface. Consequently, the EC
coupling characteristics of these myotubes might be
perturbed because the rerouting of the DHPR away from
peripheral couplings could actually reduce the DHPR
density at functional EC coupling sites. To determine if the
double cysteine motif modified the EC coupling character-
istics, we investigated the recovery of Ca2þ transients
produced by b2aD1–3b1aD4,5 and b2aC3,4SD1–3b1aD4,
5 in b1 KO myotubes. Table 2 indicates that the former
chimera was able to bypass the inhibitory signal from RyR1
and, therefore, express high-density Ca2þ currents in RyR1
KO myotubes. However, the latter chimera was not. Addi-
tionally, both chimeras had the C-terminal half of b1a, which
is essential for fast skeletal-type EC coupling (Sheridan
et al., 2002). Transfected cells were loaded with fluo-4 AM,
and Ca2þ transients were elicited under voltage-clamp con-
ditions. Ca2þ-dependent fluorescence was measured in a
confocal microscope in line-scan mode. We used voltage
steps in the range of 30 mV to þ90 mV from a hold-
ing potential of 40 mV to cover both the inward and out-
ward phases of the Ca2þ current. To avoid cell fatigue and to
allow for fluorescence recovery, we limited the number of
depolarizations to seven, and each pulse was applied every
30 s. Fig. 9 A and C show the same stimulation protocols
in b1 KO myotubes expressing b2aD1–3b1aD4,5 and
b2aC3,4SD1–3b1aD4,5. The line scan images in pseudo-
color correspond to one thousand (1000) 512-pixel lines
stacked vertically from left to right with a total acquisition
time (horizontal) of 2.05 s. The time course of the space-
averaged fluorescence intensity is shown above each image,
and the width of the square bar reflects the duration of the
pulse. Ca2þ currents during the 50-ms depolarization are
shown in expanded time scale next to each line-scan. In both
cases, Ca2þ transient amplitudes increased with stimulus
intensity and saturated at potentials more positive than þ30
mV. The decay phase after the stimulation was also similar.
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Ca2þ currents underwent a reversal in polarity which is
clearly seen by comparing depolarizations to þ50 and þ90
mV. However, this reduction in Ca2þ entry at positive
potentials had no effect on the magnitude of the elicited Ca2þ
transients. This result strongly suggested that skeletal-type
EC coupling was recovered in both cases. To quantify the
data, the maximal fluorescence during the stimulation in
resting fluorescence units (DF/Fo) was plotted as a function
of the depolarization potential and the mean fitted according
to a Boltzmann distribution (Eq. 1). This is shown in Fig. 9 B
and D for b1 KO myotubes expressing b2aD1–3b1aD4,5
and b2aC3,4SD1–3b1aD4,5, respectively. The fluorescence
versus voltage relationship increased in a sigmoidal manner,
and the parameters of the fit were similar (see legend of Fig.
9). A statistical analysis of the fluorescence versus voltage
curve of each cell further corroborated that the maximal
fluorescence reached at positive potentials was not signifi-
cantly different (DF/Fo max ¼ 3.1 6 0.4 and 3.5 6 0.2 DF/
Fo for b2aD1–3b1aD4,5 and b2aC3,4SD1–3b1aD4,5,
respectively, with t-test significance p ¼ 0.34). These results
clearly demonstrated that the double cysteine motif did not
modify the EC characteristics of myotubes. Thus, at least in
the b1 KO myotube, the two tested constructs were equally
targeted to functional EC coupling sites.
DISCUSSION
In the present work, we investigated the role of the b-subunit
of the DHPR in Ca2þ current and charge movement
expression in myotubes deficient in RyR1, which is a critical
modulator of DHPR function (Nakai et al., 1996, 1998;
Avila and Dirksen, 2000; Avila et al., 2001). The main
features of this work are: 1) Myotubes expressing b1a
accumulated a higher density of DHPR charge movements
than those expressing b2a either in the absence or presence
of RyR1. The data were especially compelling in b1/RyR1
KO myotubes where the low-background made it possible to
demonstrate that the b1a-specific charge was approximately
twice the b2a-specific charge. However, the comparatively
larger charge movements recovered by b1a did not produce
a proportional increase in Ca2þ current density. 2) The b2a-
expressing myotube had a wild-type Ca2þ current density
either in the presence or absence of RyR1. Thus, RyR1 is not
indispensable for DHPR Ca2þ current expression in skeletal
myotubes when the heterologous b2a subunit is present. The
signal for RyR1-independent Ca2þ current expression was
a double cysteine motif present at the N-terminus of b2a and
could be transferred to b1a, provided that b2a domains D1,
D2, and D3 were also transferred. Tethering b2a to the
myotube surface in the absence of the two vicinal cysteines
also increased Ca2þ current expression. 3) The EC coupling
characteristics recovered in b1 KO myotubes by b variants,
with and without the double cysteine motif, were the same.
Observations 1), pertaining specifically to the behavior of
b1a, carry significant implications for the cellular events
controlling expression of Ca2þ current and EC coupling
voltage sensors in the skeletal myotube. Observations 2)
demonstrated that an ad hoc mechanism exists in b2a, an
isoform not endogenously expressed in skeletal myotubes,
for bypassing the inhibition of Ca2þ current expression
imposed by the absence of RyR1. Finally, observations 3)
show that the double cysteine motif does not impinge on the
ability of the DHPR to be functionally coupled to RyR1.
Coexpression studies in amphibian oocytes previously
showed that the a1E/b1a subunit pair expressed significantly
more gating current and less Ca2þ current than the a1E/b2a
FIGURE 8 Participation of domains D1–D3
of b2a in Ca2þ current expression in RyR1 KO
myotubes.A) Ca2þ currents are shown in RyR1
KO myotubes expressing the indicated con-
struct. The diagrams depict domains D1–D5
with b1a sequence in black and b2a sequence
in gray. b1a Q3C, K4C corresponds to wild-
type b1a with glutamine and lysine at positions
three and four replaced by cysteines.
b2aD1b1aD2–5 corresponds to the chimera
b2a 1–16/b1a 58–524. b2aD1–3b1aD4,5 cor-
responds to the chimera b2a 1–287/b1a 325–
524. b2aC3,4SD1–3b1aD4,5 corresponds to
the chimera b2a C3,4S 1–287/b1a 325–524.
Ca2þ currents were elicited by 500-ms depola-
rizations from a holding potential of40 mV to
10, þ40, and an intermediate voltage which
was þ25 mV for b1a Q3C, K4C, þ20 mV for
b2aD1b1aD2–5, þ10 mV for b2aD1–
3b1aD4,5 and 25 mV for b2aC3,4SD1–
3b1aD4,5. The intermediate voltage was close to the half-activation potential for each construct. Scale bars are 1 nA and 100 ms for all cells. B) Voltage
dependence of the Ca2þ conductance in RyR1 KO myotubes. Symbols show the mean conductance (6 SE) for the number of cells indicated in Table 2. The
lines are a fit of the mean conductance according to Eq. 1. The parameters of the fit withGmax in pS/pF,V1/2 in mV, and k in mV are 42.1, 29.7, and 5.4 for b1a
Q3C, K4C ( ﬁlled diamonds); 58.1, 23.9, and 4.7 for b2aD1b1aD2–5 (empty triangles); 171.4, 9.9, and 5.6 for b2aD1–3b1aD4,5 (empty circles); and 62.8,
22.7, and 6.8 for b2aC3,4SD1–3b1aD4,5 ( ﬁlled inverted triangles).
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pair (Noceti et al., 1996). In a1E/b1a channels, a significant
fraction of the expressed intramembrane charges were
determined to be peripheral to the gating process and were
not coupled to the actual opening of the pore. Such ‘‘silent’’
or low-conducting channels contributed to the total cell
charge but not to the Ca2þ current. Studies in b1 KO
myotubes also indicated that the b1a and b2a variants
produced a differential recovery of Ca2þ currents and charge
movements (Beurg et al., 1999a). In this expression system,
b1a and b2a restored the same Ca2þ current density, and the
nonstationary variance properties of the Ca2þ currents were
also similar. On the other hand, the density of DHPR charge
movement restored by a1S/b2a complexes was significantly
lower than that restored by a1S/b1a complexes, and this
observation was confirmed in the present study. The
previous study could not pinpoint the contribution of
RyR1, because the latter is constitutively present in the b1
KO myotube (Gregg et al., 1996). We have now shown that,
in the absence of RyR1, b1a promoted expression of DHPR
charge movements; however, Ca2þ current expression was
minimal. By contrast, b2a modulated DHPR function in the
opposite direction, namely, toward more Ca2þ current and
less charge movement expression. Hence, the inability of the
native skeletal DHPR to express Ca2þ currents appears to be
dictated by the properties of the b-subunit possibly in
combination with molecular determinants elsewhere in the
DHPR. In this respect, it is important to mention that the
C-terminus of a1 subunits is known to play a role in Ca2þ
channel regulation, serving as a binding site for b-subunits in
some a1/b pairs (Walker et al., 1998; Tareilus et al., 1997),
and promoting surface expression of a1C and a1S channels
(Gao et al., 2000; Proenza et al., 2000).
In terms of a molecular mechanism, we can provide few
clues on how b1a, in the context of the myotube lacking
RyR1, stimulates expression of a large density of voltage-
sensing DHPRs but a low-density Ca2þ current. It is
conceivable that domains of b1a keep the skeletal DHPR
in a low-conducting state which, in the normal myotube,
would be removed by RyR1. For example, b1a could act in
this case as a blocking particle or could inhibit gating
transitions preventing the channel from reaching the open
conformation. The present studies formally ruled out
participation of variable domains D1, D3, and D5 of b1a
in such a process (Fig. 6). Another possibility here is that two
different b-subunits could have evolved in skeletal muscle
for regulating the two functions of the DHPR. One b-isoform
could be specialized for activation of the Ca2þ current, while
b1a could be specialized for EC coupling, a process which
does not require activation of the Ca2þ current. A reasonable
candidate b for the pore function is b1b, because it is
produced by alternative splicing of the same skeletal b1 gene
(Powers et al., 1992) and is expressed at low levels in
myotubes (Ren and Hall, 1997). Additionally, studies in
amphibian oocytes indicated that b1b, in combination with
the rest of the skeletal subunits, expresses skeletal Ca2þ
currents of a comparatively large magnitude relative to
FIGURE 9 Absence of a contribution of the
double cysteine motif to EC coupling recovery
in b1 KO myotubes. A and C) Confocal Ca2þ
transients at the indicated potentials are shown
for b1 KO myotubes expressing either b2aD1–
3b1aD4,5 (C ¼ 164 pF), or b2aC3,4SD1–
3b1aD4,5 (C ¼ 182 pF). Myotubes were held
at 40 mV and depolarized to the indicated
potentials. The time course of the transient was
obtained by integration of line scan images of
fluo-4 fluorescence. The 50-ms depolarization
used to stimulate the Ca2þ transient is indicated
by the square pulse. The Ca2þ current during
the depolarization is shown expanded next to
each line scan at the same scale. For visual
reference, pseudocolors, in DF/Fo units, are
blue \0.2; yellow \2; and red \4. In the
images, the total line scan duration (x axis) was
2.05 seconds and the cell dimension (y axis)
was (in microns) 17.5 for b2aD1–3b1aD4,5
and 23.5 for b2aC3,4SD1–3b1aD4,5. B and
D) Voltage dependence of the mean peak
fluorescence (6 SE) during the Ca2þ transient
in DF/Fo units. The lines are a fit of the mean
DF/Fo according to Eq. 1. The parameters of
the fit with Fmax in DF/Fo, V1/2 in mV, and k
in mV are 3.1, 0.6, and 8.5 for b2aD1–
3b1aD4,5 (empty triangles, 8 cells); and 3.6,
1.2, and 7.1 for b2aC3,4SD1–3b1aD4,5 (ﬁlled
triangles, 5 cells).
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controls with b1a (Ren and Hall, 1997). One would have
thus predicted that b1b had the ability to rescue DHPR Ca2þ
currents in skeletal myotubes. However, the screen con-
ducted in the RyR1 KO showed that this was not the case
(Fig. 6). We further tested Ca2þ current recovery by b1b in
the RyR1-expressing b1 KO myotube. In this myotube
genotype, b1b recovered a DHPR Ca2þ current with
Boltzmann parameters Gmax ¼ 56 6 9.4 pS/pF, V1/2 ¼
20.9 6 1.5 mV and k ¼ 5.7 6 0.6 mV in 6 cells. Hence, in
the skeletal myotube, b1b is a weak expressor of skeletal
Ca2þ currents and furthermore, this variant has no ability to
restore EC coupling (not shown). Therefore, based on these
experiments, the idea that b1b might be involved in
differential regulation of Ca2þ current expression in skeletal
myotubes is tenuous. It could be that in the skeletal myotube,
b1b is unable to traffic the skeletal DHPR to the cell surface
efficiently or it might impair targeting of the DHPR to EC
coupling sites. It remains to be determined if low level
expression of variants from other b-genes could potentially
contribute to Ca2þ current expression in RyR1 KO myo-
tubes.
Several studies have shown that the double cysteine motif
of b2a constitutes a signal for covalent palmitoylation, which
promotes anchoring of the subunit to the cell membrane
(Chien et al., 1998; Qin et al., 1998; Restituto et al., 2000). In
studies of expression of the a1C/b2a pair in tsA201 cells,
removal of the double cysteine motif and replacement of the
two positions with serines decreased the Ca2þ current
density (Chien et al., 1996). In the RyR1 KO myotube,
b2a C3,4S reverted the increase in Ca2þ conductance seen
with wild-type b2a (Fig. 7). Given the similarity of our
results to those in tsA201 cells, it is possible that
palmitoylation of b2a, in combination with domains D1–
D3 of b2a, accounts for the large Ca2þ current expression
observed in RyR1 KO myotubes. However, the results with
the b2a-b1a chimeras showed that neither the double
cysteine motif alone nor the entire D1 domain of b2a were
sufficient for Ca2þ current recovery (Fig. 8). Hence,
additional structural determinants, besides those required
for palmitoylation of the b-subunit, may be at play in the
skeletal myotube. Restituto et al. (2000) showed in tsA201
cells that a b2a subunit with the palmitoylation signal
replaced by a membrane-anchoring domain of the surface
glycoprotein CD8A mimicked the modulation of Ca2þ
currents observed with wild-type b2a. In this system, the
physical anchoring of the b2a subunit to the cell surface
prevented voltage-dependent inactivation of the Ca2þ
current expressed by the neuronal a1A pore subunit. This
result suggested that b2a was a molecular component of the
‘‘inactivation gate’’ of the neuronal Ca2þ channel. We tested
the CD8-b2a C3,4S fusion construct described by Restituto
et al. (2000) and found that the membrane-anchored b2a,
like wild-type b2a, had the ability to stimulate Ca2þ current
expression in the absence of RyR1. Hence, a mechanism
involving anchoring of the heterologous b2a variant to the
surface membrane was likely responsible for the Ca2þ
current stimulation observed in the RyR1 KO myotube.
However, because b1 variants are not palmitoylated in
mammalian cells (Chien et al., 1996), the findings with b2a
may not represent a mechanism for enhancing Ca2þ current
expression in skeletal muscle in situ. Even so, the ability of
CD8-b2a C3,4S for bypassing the requirement of RyR1
could serve to outline a potential mechanism of physiolog-
ical importance. For instance, it would be interesting to
investigate in the future whether the b1a subunit could
actually bind to the myotube surface membrane by other
means and whether this interaction might modulate the pore
function of the skeletal DHPR.
It could be argued that in the RyR1 KO, b-variants with
a palmitoylation signal might have stimulated the transport
of the skeletal DHPR to surface sites away from EC coupling
sites and that the ability of the relocated DHPR to express
Ca2þ current may be derived from these new locations. In
this respect, surface sites such as caveolae, which are known
to orchestrate cell signaling and possibly modulate myotube
Ca2þ currents (Strube et al., 2002), deserve some consider-
ation. It is also possible that palmitoylated b-variants might
have recruited nonskeletal pore isoforms which could have
become reexpressed in the RyR1 KO myotube due to
unforeseen pleotropic effects. Thus, in one scenario, the
Ca2þ current promoted by b2a in the RyR1 KO might have
originated from a DHPR formed from a non-a1S isoform
sparsely present throughout the myotube surface. In an
opposite scenario, the Ca2þ current promoted by b2a might
have originated from a DHPR containing an a1S isoform
and present in peripheral couplings where EC coupling sites
are assembled and where the DHPR remains concentrated
even in the absence of RyR1 (Takekura et al., 1994; Protasi
et al., 1998). The functional evidence gathered in this work
and in a recent study on the EC coupling characteristics of
b2a-b1a chimeras (Sheridan et al., 2002) indicates that the
latter possibility is far more likely. First, the activation
kinetics of the Ca2þ current expressed by b2a in the RyR1
KO was even slower than that expressed by the control b1a
(Fig. 4). Hence, b2a recovered a slow skeletal-type Ca2þ
current and not the much faster Ca2þ current seen by
expression of the cardiac a1C or the neuronal a1A in a1S-
null dysgenic myotubes (Garcia et al., 1994; Adams et al.,
1994). This result would not be expected if b2a had paired
up with a1C or a1A. Second, transfection of b2a in
a dysgenic a1S-null myotube does not result in expression of
Ca2þ currents (not shown). Therefore, a1S is essential for
the b-mediated recovery of DHPR function in skeletal
myotubes. Furthermore, a1C expression could not be
detected by immunofluorescence in b1 KO myotubes
expressing b2a (Sheridan et al., 2002). Hence, pleotropic
effects are unlikely. Third, Ca2þ currents recovered by wild-
type b1a and b2a in b1 KO and RyR1 KO myotubes and by
CD8-b2a C3,4S in RyR1 KO myotubes were blocked by
1 mM nifedipine (not shown). Thus, the recovered currents
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are DHP sensitive, whereas those expressed by a1A are not
(Adams et al., 1994). Finally, we could not detect significant
differences in the EC coupling abilities of b2a-b1a chimeras
with and without the double cysteine motif (Fig. 9). This
result indicates that the double cysteine motif does not have
an intrinsic ability to relocate the DHPR to new sites in the
myotube surface away from the region of peripheral
couplings. However, because functional EC coupling re-
covery is only possible in b1 KO myotubes but not RyR KO
myotubes, this result does not entirely preclude the
possibility of DHPR relocation in the RyR1 KO myotube.
The latter possibility remains open to investigation by
structural and/or immunocytochemical techniques.
Finally, it must be recognized that when RyR1 is present,
the interactions between the DHPR and RyR1 modify the
gating properties of the DHPR Ca2þ channel in a significant
manner, which has been shown by expression studies in
RyR1 KO myotubes (Avila and Dirksen, 2000; Avila et al.,
2001) and by Ca2þ current recordings in vesicles derived
from skeletal muscle surface membranes (Camacho et al.,
1999). The double b1/RyR1 KO myotube could be a useful
expression system for analyzing the intrinsic properties of
the DHPR separately from those modulated by RyR1. The
double a1/RyR1 KO myotube (Protasi et al., 2002) could
serve for the same purpose.
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